AKT1 and pulmonary fibrosis: NOB inhibits amiodarone-induced pulmonary fibrosis by inhibiting the TGF-β3-related PI3K/AKT/mTOR cascade, inhibiting alpha smooth muscle actin (α-SMA) expression and hindering collagen deposition.[53]